SEC Info - Molina Healthcare, Inc. - ‘10-K’ for 12/31/23

SEC Info℠

Home

My Interests

Help

Please Sign In

Molina Healthcare, Inc. – ‘10-K’ for 12/31/23 – ‘EX-31.2’

On: Tuesday, 2/13/24, at 5:16pm ET · For: 12/31/23 · Accession #: 1179929-24-33 · File #: 1-31719

Previous ‘10-K’: ‘10-K’ on 2/13/23 for 12/31/22 · Latest ‘10-K’: This Filing · 17 References:

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/13/24  Molina Healthcare, Inc.           10-K       12/31/23  122:32M

Annual Report — Form 10-K — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.09M 
 2: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     32K 
 3: EX-3.3      Articles of Incorporation/Organization or Bylaws    HTML     31K 
 4: EX-10.3     Material Contract                                   HTML     64K 
 5: EX-10.4     Material Contract                                   HTML    161K 
 6: EX-21.1     Subsidiaries List                                   HTML     40K 
 7: EX-23.1     Consent of Expert or Counsel                        HTML     31K 
12: EX-97       Clawback Policy re: Recovery of Erroneously         HTML     44K 
                Awarded Compensation                                             
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     36K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     36K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     33K 
18: R1          Cover Page                                          HTML     99K 
19: R2          Audit Information                                   HTML     37K 
20: R3          Consolidated Statements of Income                   HTML    123K 
21: R4          Consolidated Statements of Comprehensive Income     HTML     58K 
22: R5          Consolidated Balance Sheets                         HTML    127K 
23: R6          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
24: R7          Consolidated Statements of Stockholders? Equity     HTML     79K 
25: R8          Consolidated Statements of Cash Flows               HTML    123K 
26: R9          Organization and Basis of Presentation              HTML     39K 
27: R10         Significant Accounting Policies                     HTML     91K 
28: R11         Net Income Per Share                                HTML     56K 
29: R12         Business Combinations                               HTML     48K 
30: R13         Fair Value Measurements                             HTML     93K 
31: R14         Investments                                         HTML    138K 
32: R15         Property, Equipment, and Capitalized Software, Net  HTML     60K 
33: R16         Leases                                              HTML    137K 
34: R17         Goodwill and Intangible Assets, Net                 HTML     69K 
35: R18         Medical Claims and Benefits Payable                 HTML    150K 
36: R19         Debt                                                HTML     66K 
37: R20         Income Taxes                                        HTML     94K 
38: R21         Stockholders' Equity                                HTML     89K 
39: R22         Employee Benefit Plans                              HTML     35K 
40: R23         Commitments and Contingencies                       HTML     46K 
41: R24         Segments                                            HTML     70K 
42: R25         Condensed Financial Information of Registrant       HTML    147K 
43: R26         Pay vs Performance Disclosure                       HTML     44K 
44: R27         Insider Trading Arrangements                        HTML     38K 
45: R28         Significant Accounting Policies (Policies)          HTML    120K 
46: R29         Significant Accounting Policies (Tables)            HTML     61K 
47: R30         Net Income Per Share (Tables)                       HTML     56K 
48: R31         Business Combinations (Tables)                      HTML     47K 
49: R32         Fair Value Measurements (Tables)                    HTML     91K 
50: R33         Investments (Tables)                                HTML    138K 
51: R34         Property, Equipment, and Capitalized Software, Net  HTML     58K 
                (Tables)                                                         
52: R35         Leases (Tables)                                     HTML    100K 
53: R36         Goodwill and Intangible Assets, Net (Tables)        HTML     73K 
54: R37         Medical Claims and Benefits Payable (Tables)        HTML    154K 
55: R38         Debt (Tables)                                       HTML     66K 
56: R39         Income Taxes (Tables)                               HTML     96K 
57: R40         Stockholders' Equity (Tables)                       HTML     84K 
58: R41         Segments (Tables)                                   HTML     65K 
59: R42         Condensed Financial Information of Registrant       HTML    148K 
                (Tables)                                                         
60: R43         Organization and Basis of Presentation (Details)    HTML     48K 
61: R44         Significant Accounting Policies - Cash, Cash        HTML     41K 
                Equivalents, and Restricted Cash (Details)                       
62: R45         Significant Accounting Policies - Additional        HTML     80K 
                Information (Details)                                            
63: R46         Significant Accounting Policies - Receivables       HTML     40K 
                (Details)                                                        
64: R47         Net Income Per Share (Details)                      HTML     78K 
65: R48         Business Combinations - Narrative (Details)         HTML     56K 
66: R49         Business Combinations - Schedule of The             HTML     56K 
                Provisional Fair Values Assigned To Assets                       
                Acquired and Liabilities Assumed (Details)                       
67: R50         Business Combinations - Intangible Assets           HTML     44K 
                (Details)                                                        
68: R51         Fair Value Measurements - Financial Instruments on  HTML     81K 
                a Recurring Basis (Details)                                      
69: R52         Fair Value Measurements - Additional Information    HTML     38K 
                (Details)                                                        
70: R53         Fair Value Measurements - Long-Term Debt (Details)  HTML     54K 
71: R54         Investments - Schedule of Investments (Details)     HTML     63K 
72: R55         Investments - Contractual Maturities (Details)      HTML     59K 
73: R56         Investments - Narrative (Details)                   HTML     50K 
74: R57         Investments - Available-for-Sale (Details)          HTML     78K 
75: R58         Investments - Balances of Restricted Investments    HTML     45K 
                (Details)                                                        
76: R59         Property, Equipment, and Capitalized Software, Net  HTML     50K 
                - Additional Information (Details)                               
77: R60         Property, Equipment, and Capitalized Software, Net  HTML     55K 
                - Summary of Property, Equipment, and Capitalized                
                Software (Details)                                               
78: R61         Property, Equipment, and Capitalized Software, Net  HTML     43K 
                - Depreciation and Amortization (Details)                        
79: R62         Leases - Narrative (Details)                        HTML     51K 
80: R63         Leases - Components of Lease Expense (Details)      HTML     42K 
81: R64         Leases - Supplemental Cash Flow (Details)           HTML     47K 
82: R65         Leases - Supplemental Balance Sheet Information     HTML     62K 
                (Details)                                                        
83: R66         Leases - Lease Maturities (Details)                 HTML     72K 
84: R67         Goodwill and Intangible Assets, Net - Balances of   HTML     46K 
                Goodwill (Details)                                               
85: R68         Goodwill and Intangible Assets, Net - Intangible    HTML     47K 
                Assets Balances (Details)                                        
86: R69         Goodwill and Intangible Assets, Net - Additional    HTML     43K 
                Information (Details)                                            
87: R70         Medical Claims and Benefits Payable - Medical       HTML     41K 
                Claims and Future Benefits (Details)                             
88: R71         Medical Claims and Benefits Payable - Additional    HTML     35K 
                Information (Details)                                            
89: R72         Medical Claims and Benefits Payable - Components    HTML     76K 
                of the Change (Details)                                          
90: R73         Medical Claims and Benefits Payable - Incurred      HTML     50K 
                Claims and Allocated Adjustment Expense (Details)                
91: R74         Medical Claims and Benefits Payable - Cumulative    HTML     41K 
                Paid Claims and Allocated Claims Adjustment                      
                Expenses (Details)                                               
92: R75         Medical Claims and Benefits Payable -               HTML     46K 
                Reconciliation of Claims Development (Details)                   
93: R76         Debt - Maturities (Details)                         HTML     73K 
94: R77         Debt - Schedule of Long-Term Debt (Details)         HTML     54K 
95: R78         Debt - Credit Agreement (Details)                   HTML     42K 
96: R79         Debt - Senior Notes (Details)                       HTML     51K 
97: R80         Income Taxes - Provision for Income Taxes           HTML     55K 
                (Details)                                                        
98: R81         Income Taxes - Reconciliation of the U.S. Federal   HTML     44K 
                Statutory Income Tax Rate (Details)                              
99: R82         Income Taxes - Deferred Tax Assets and Liabilities  HTML     65K 
                (Details)                                                        
100: R83         Income Taxes - Additional Information (Details)     HTML     50K  
101: R84         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     39K  
102: R85         Stockholders' Equity - Additional Information       HTML    111K  
                (Details)                                                        
103: R86         Stockholders' Equity - Components of Share-based    HTML     49K  
                Compensation (Details)                                           
104: R87         Stockholders' Equity - Restricted and Performance   HTML     64K  
                Stock Activity (Details)                                         
105: R88         Stockholders' Equity - Fair Value of Awards         HTML     47K  
                Granted and Vested (Details)                                     
106: R89         Stockholders' Equity - Stock Option Activity        HTML     50K  
                (Details)                                                        
107: R90         Employee Benefit Plans (Details)                    HTML     37K  
108: R91         Commitments and Contingencies (Details)             HTML     47K  
109: R92         Segments - Narrative (Details)                      HTML     33K  
110: R93         Segments - Schedule of Operating Segment            HTML     49K  
                Information (Details)                                            
111: R94         Segments - Reconciliation of Gross Margin to        HTML     66K  
                Consolidated Income (Details)                                    
112: R95         Condensed Financial Information of Registrant -     HTML    135K  
                Condensed Balance Sheets (Details)                               
113: R96         Condensed Financial Information of Registrant -     HTML     56K  
                Condensed Balance Sheets - Additional Information                
                (Details)                                                        
114: R97         Condensed Financial Information of Registrant -     HTML     98K  
                Condensed Statements of Operations (Details)                     
115: R98         Condensed Financial Information of Registrant -     HTML     64K  
                Condensed Statements of Comprehensive Income                     
                (Details)                                                        
116: R99         Condensed Financial Information of Registrant -     HTML     88K  
                Condensed Statements of Cash Flows (Details)                     
117: R100        Condensed Financial Information of Registrant -     HTML     45K  
                Notes to Condensed Financial Information (Details)               
119: XML         IDEA XML File -- Filing Summary                      XML    216K  
122: XML         XBRL Instance -- moh-20231231_htm                    XML   3.01M  
118: EXCEL       IDEA Workbook of Financial Report Info              XLSX    212K  
14: EX-101.CAL  XBRL Calculations -- moh-20231231_cal                XML    304K 
15: EX-101.DEF  XBRL Definitions -- moh-20231231_def                 XML    817K 
16: EX-101.LAB  XBRL Labels -- moh-20231231_lab                      XML   2.36M 
17: EX-101.PRE  XBRL Presentations -- moh-20231231_pre               XML   1.53M 
13: EX-101.SCH  XBRL Schema -- moh-20231231                          XSD    220K 
120: JSON        XBRL Instance as JSON Data -- MetaLinks              666±  1.01M  
121: ZIP         XBRL Zipped Folder -- 0001179929-24-000033-xbrl      Zip    893K

‘EX-31.2’ — Certification — §302 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

C: C:

Document

EXHIBIT 31.2

CERTIFICATION

I, Mark L. Keim, certify that:

1. I have reviewed this Annual Report on Form 10-K for the period ended December 31, 2023 of Molina Healthcare, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Dated: February 13, 2024						/s/ *Mark L. Keim*
						Mark L. Keim
						Chief Financial Officer and Treasurer
						(Principal Financial Officer)

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

Filed on:	2/13/24	SC 13G/A
For Period end:	12/31/23
		List all Filings

17 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/27/23  Molina Healthcare, Inc.           10-Q        3/31/23   61:53M
10/27/22  Molina Healthcare, Inc.           10-Q        9/30/22   65:8.2M
 2/16/22  Molina Healthcare, Inc.           8-K:5,9     2/16/22   11:175K
 2/14/22  Molina Healthcare, Inc.           10-K       12/31/21  118:14M
11/16/21  Molina Healthcare, Inc.           8-K:1,2,8,911/16/21   12:27M
 9/09/21  Molina Healthcare, Inc.           8-K:1,5,7,9 9/08/21   12:365K                                   Business Wire/FA
 2/16/21  Molina Healthcare, Inc.           10-K       12/31/20  122:15M
11/17/20  Molina Healthcare, Inc.           8-K:1,2,8,911/17/20   12:961K                                   Business Wire/FA
 6/08/20  Molina Healthcare, Inc.           8-K:1,9     6/08/20   11:1.2M                                   Business Wire/FA
 6/02/20  Molina Healthcare, Inc.           8-K:1,2,8,9 6/02/20   12:922K                                   Business Wire/FA
10/30/19  Molina Healthcare, Inc.           10-Q        9/30/19   82:10M
 7/31/19  Molina Healthcare, Inc.           10-Q        6/30/19   85:18M
 2/19/19  Molina Healthcare, Inc.           10-K       12/31/18  137:39M
 6/14/13  Molina Healthcare, Inc.           8-K:1,5,9   6/14/13    4:171K                                   Donnelley … Solutions/FA
 2/28/13  Molina Healthcare, Inc.           10-K       12/31/12  127:25M                                    Workiva Inc.
 3/14/07  Molina Healthcare, Inc.           10-K       12/31/06   14:9.3M                                   Donnelley … Solutions/FA
12/30/02  Molina Healthcare, Inc.           S-1                   21:4.9M                                   Donnelley Fin’l S… 05/FA

↑Top

Filing Submission 0001179929-24-000033 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)